US Approves Ramp-up Plan of Bavarian Nordic’s Monkeypox Vaccine
On Wednesday, July 27, 2022, the US Food and Drug Administration (FDA) gave approval to the plans of Bavarian Nordic to ramp up production of its JYNNEOUS vaccine that is used in efforts to halt a global outbreak of monkeypox disease. This move comes as monkeypox cases increase globally, which forced the World Health Organization […]
Continue Reading